Does a breast biopsy hurt?

The radiologist injects a local anesthetic first, so the area goes numb within seconds. Most people feel a pin prick and a short stinging sensation, then pressure rather than pain. Soreness and bruising for a day or two are common afterward.

Can I drive myself home after a needle biopsy?

Needle biopsies use local anesthetic only, and you stay awake, so most centers treat them as same-day outpatient visits. Ask your facility in advance, since policies vary. A surgical biopsy with general anesthesia does require someone to drive you.

Do I have to get the marker clip taken out later?

No. The American Cancer Society states the marker stays in place, is safe during MRI scans, and will not trigger metal detectors. It simply shows future imaging where tissue was sampled. If surgery happens later, the surgeon removes it with the tissue.

Can a needle biopsy miss a cancer?

It can, which is why radiologists compare the pathology result with the imaging. If a benign result does not explain a highly suspicious image, they may recommend repeat sampling or surgical excision. This concordance check is a routine part of breast biopsy practice.

How soon can I exercise or lift after the biopsy?

Standard advice is to avoid strenuous activity for at least 24 hours, then resume normal activity. Cold packs and over-the-counter pain relievers help with swelling. Follow the specific instructions your breast center gives you, especially after a vacuum-assisted or surgical biopsy.

What Happens During A Breast Biopsy?

The short answer: A breast biopsy removes a small tissue sample so a pathologist can examine it under a microscope. Most are needle biopsies, done with a local anesthetic and guided by ultrasound, mammography or MRI. The appointment usually finishes within an hour, and a tiny marker clip is often left at the site. Most results are not cancer: the American Cancer Society reports that about 90% of abnormal findings on an initial mammogram turn out to be benign.

How many breast biopsies turn out to be benign?

This is the number most people want first. The American Cancer Society states that about 1 in 10 screening mammograms is abnormal, and that in about 90% of those cases the finding is benign.

Biopsy data points the same way. The Breast Cancer Surveillance Consortium linked 4,020,140 mammograms to 76,567 pathology specimens collected between 1996 and 2008. Only 1.2% of screening mammograms and 6.8% of diagnostic mammograms were followed by a biopsy. Among biopsies done after a screening mammogram, 19.8% showed invasive carcinoma. After a diagnostic mammogram, that figure was 29.3%.

So roughly 4 in 5 biopsies following a screening mammogram found no invasive cancer. A smaller share showed ductal carcinoma in situ or a high-risk lesion, and the rest were benign. MedlinePlus puts it plainly: most breast lumps and other changes checked with biopsies turn out to be benign.

Over time, the odds still favor you. BCSC researchers report that after 10 years of annual screening, 50% to 60% of women have at least one false-positive recall, and 7% to 12% have a benign biopsy. If you are still in the callback stage, our guide to mammogram callbacks covers what happens before a biopsy is ordered.

What are the main types of breast biopsy?

The National Cancer Institute groups them into a few clear categories in its breast cancer diagnosis overview:

Fine-needle aspiration (FNA). A thin needle draws out fluid or a small number of cells. It samples cells rather than a block of tissue, so it is used less often for solid breast lesions.
Core-needle biopsy. A wider hollow needle removes cylinders of tissue called cores. The American Cancer Society notes the needle may be attached to a spring-loaded tool or a suction device.
Vacuum-assisted biopsy. This is a core biopsy with a vacuum-powered device. It pulls tissue into the needle and collects several samples through one insertion.
Surgical biopsy. An incisional biopsy removes part of a lump. An excisional biopsy removes the whole lump, sometimes with a rim of normal tissue.

Stereotactic, ultrasound-guided and MRI-guided are not separate tissue-sampling methods. They describe the imaging used to steer the needle. The American Cancer Society lists the factors that decide which route you get: how suspicious the change looks, how big it is, where it sits in the breast, whether there is more than one area, your overall health and your preferences.

Which imaging guides the needle?

NCI explains that ultrasound, mammography or MRI can guide a needle to the target. When mammography does the guiding, the procedure is called a stereotactic biopsy.

Ultrasound guidance works well for masses the radiologist can see on sound-wave imaging. You lie face up or slightly turned. The radiologist watches the needle move in real time.
Stereotactic guidance is the usual choice for findings visible only on mammography, such as tiny calcium deposits. The machine takes images from two angles to fix the target in three dimensions. Learn more about what breast calcifications mean on a mammogram.
MRI guidance is used for a suspicious area seen only on breast MRI. It needs an intravenous line and gadolinium contrast. For wider imaging explainers, see mri.md.

Stereotactic biopsy has limits. The ACR and RSNA patient resource notes it may not work when the abnormality sits near the chest wall or directly behind the nipple, or when the breast is very thin.

What happens during the appointment?

Preparation is light. You may be told to stop aspirin, blood thinners or certain herbal supplements three to five days beforehand. Skip deodorant, talcum powder and lotion on your chest and underarms that day. Wear loose clothes and leave jewelry at home.

Positioning depends on the imaging. For stereotactic and MRI-guided biopsies you usually lie face down on a moveable table, with the breast through an opening. For ultrasound-guided biopsies you lie face up or turned slightly to the side.

The radiologist then injects a local anesthetic into the skin and deeper into the breast. You feel a pin prick and a brief stinging sensation, then numbness within seconds. You stay awake. NCI notes that only surgical biopsies use local or general anesthesia in an operating room.

Sampling is quick. A core needle typically takes one sample per insertion, with three to six passes. A vacuum-assisted device collects 8 to 10 samples in a single insertion under ultrasound, and roughly 3 to 12 samples in a stereotactic procedure. Ultrasound-guided and stereotactic biopsies are usually completed within an hour. MRI-guided biopsy is usually completed within 45 minutes.

Near the end, the radiologist often places a marker clip at the biopsy site. NCI calls it a small metal clip that marks the spot for any future procedures. The American Cancer Society confirms the marker shows up on mammograms, stays in place, is safe during MRI scans and will not set off metal detectors. A mammogram is then taken to confirm the marker sits in the right position.

What does recovery look like?

Needle biopsies are outpatient procedures. You go home the same day. Stitches are usually not needed, and a core needle biopsy usually does not leave a scar.

The standard instruction is to avoid strenuous activity for at least 24 hours. The American Cancer Society phrases it as limiting strenuous activity for a day or so, then returning to normal activities. Cold packs and over-the-counter pain relievers help if the area swells.

Expect some bleeding, bruising or swelling at the site. MedlinePlus lists bruising and temporary discomfort as the common effects, with bleeding and infection as less common risks. Call your care team if you see spreading redness, fever or drainage. Recovery after a surgical biopsy takes longer, because it involves an incision and closure.

How long do pathology results take, and what do the categories mean?

Preparing fixed tissue sections takes several days. NCI states that a pathologist typically sends the pathology report to your doctor within 10 days of the biopsy. Many breast centers are faster. Ask your radiologist who will call you and when.

MedlinePlus groups breast biopsy results into four categories: normal with no cancer, abnormal changes that do not raise cancer risk, abnormal changes that do raise cancer risk, and breast cancer. The third group includes atypical hyperplasia and lobular neoplasia, often called high-risk lesions.

A high-risk result is not a cancer diagnosis, but it can change the plan. Surgeons may recommend removing the area, because a small share of these lesions hide something more serious. One series of 90 atypical ductal hyperplasia lesions found a 28.9% upgrade rate at surgical excision, mostly to ductal carcinoma in situ, against a published range of 7% to 87% in earlier studies.

Your radiologist also checks that the pathology matches what the imaging showed. If a benign result does not explain a very suspicious image, repeat sampling may be advised. Our explainer on BI-RADS categories covers how radiologists score suspicion in the first place.

The bottom line

A breast biopsy is a short, awake, outpatient procedure in most cases. You get a local anesthetic, the needle is steered by ultrasound, mammography or MRI, a marker clip usually goes in, and you rest for a day. Results generally arrive within 10 days. The most useful fact to hold onto is the base rate: about 90% of abnormal initial mammogram findings are benign, and roughly 4 in 5 biopsies after a screening mammogram show no invasive cancer.

Last updated: September 2026. This article is for informational purposes only and does not constitute medical advice. Talk with your radiologist, breast surgeon or primary care clinician about which biopsy is right for your finding and how to read your pathology report.